Table 1 Clinical characteristics of the enrolled subjects
Variables | Total (n = 98) | Non-VCP (n = 51) | VCP (n = 47) | P |
|---|---|---|---|---|
Male, n(%) | 57(54.30) | 29(56.90) | 28(59.60) | 0.11 |
Age (years) | 72.5(43,88) | 68.5(43,88) | 72(43,82) | 0.62 |
Diabetes duration (years) | 10(0.50,23) | 11(0.50,20) | 8(1,23) | 0.93 |
BMI (kg/m2) | 24.45(18.40,28.90) | 24.68 ± 2.58 | 24.10(19.50,27.90) | 0.55 |
SBP (mmHg) | 135 ± 12 | 136(105,151) | 137 ± 12 | 0.25 |
DBP (mmHg) | 84(60,99) | 80(62,99) | 87(60,98) | 0.04 |
HbA1c (%) | 6.0 ± 1.1 | 4.8 ± 1.1 | 6.2 ± 1.0 | 0.04 |
HbA1c (mmol/mol) | 42.1 ± 14.3 | 29.0 ± 12.9 | 44.3 ± 16.7 | 0.04 |
GLU (mmol/L) | 7.0(4.8,13.8) | 6.4(5.3,11.9) | 7.9(5.3,13.8) | <0.001 |
TIR (%) | 57.50(21,82) | 67(23,82) | 49.21 ± 15.03 | <0.001 |
TBR (%) | 0(0,33) | 0(0,20) | 0(0,33) | 0.78 |
TAR (%) | 39.23(6,78) | 29(15,78) | 45.43 ± 16.03 | <0.001 |
SIRI | 0.98(0.12,3.02) | 0.66(0.23,2.96) | 1.05(0.12,3.02) | 0.001 |
CRP (mg/L) | 5.22(2, 21.60) | 3.07(0.20,21.60) | 6.75(0.30,19.50) | 0.13 |
TC (mmol/L) | 4.9 ± 1.2 | 4.8 ± 1.2 | 5.1 ± 1.2 | 0.45 |
TG (mmol/L) | 1.3(0.2,5.6) | 0.9(0.2,4.3) | 1.6(0.3,5.6) | 0.01 |
LDL-C (mmol/L) | 3.3(1.8,5.7) | 3.0(1.8,5.7) | 3.1(1.8,4.0) | 0.42 |
HDL-C (mmol/L) | 1.2(0.5,3.7) | 1.3(0.8,2.1) | 1.0(0.5,3. 7) | <0.001 |
Statin medication, n (%) | 37(37.8) | 18(35.3) | 19(40.4) | 0.60 |
Aspirin medication, n (%) | 28(28.6) | 13(25.5) | 15(31.9) | 0.48 |